First Clinical Trial Of Genetically Modified Cancer-Fighting Immune Cells Shows Great Promise
American researchers have concluded the first stage I trial run of a refreshing approach in the fight against cancer . T - cadre , a case of resistant cell , were genetically modified using the CRISPR - Cas9 technique to attack cancer cell . The team test the method on three patient in their LX with advanced cancer , whose tetraiodothyronine - cells were still actively fighting the Cancer the Crab up to nine months after the first injection ....